Back
About the Global Fund
Sixth Replenishment
People & Structures
Funding Model
�Investments & Results
-
Explore our data on investments and results in the fight against AIDS, tuberculosis and malaria around the world.
- Data Explorer
- Funding Decisions
- Data Service
- Find a Grant (Old Grant Portfolio)
HIV & AIDS
Tuberculosis
MalariaNews & Stories
-
15 November 2019
Global Fund Board Steps Up Efforts to Expand Impact Against HIV, TB and Malaria -
31 October 2019
Landmark Deal Secures Significant Discount on Price of Medicine to Prevent TB -
30 October 2019
Promises Alone Cannot Save Our Lives -
16 October 2019
How We Can Secure the Broadest Access to Quality-Assured and Affordable Medicines to Defeat HIV -
More News & Stories
-
Newsroom & Media Contacts
Feature Stories
Featured Publication
Documents By Type
The Global Fund / Karin Schermbrucker
Withdrawal of the Quality Assurance Information Notice 2016-02 regarding IPCA Ratlam Manufacturing Site
15 July 2019
The Quality Assurance Information Notice 2016-02 providing recommendations regarding the procurement and the distribution of finished pharmaceutical products using active pharmaceutical ingredients manufactured at IPCA Ratlam Manufacturing Site is withdrawn. This is to reflect the Sourcing and Supply Chain Department decision that no specific quality assurance requirements are currently implemented by Global Fund quality assurance on IPCA finished pharmaceuticals products.